Cosmo Unveils Bold 2030 Vision and Strategy; launches AI-driven Growth Phase at Investor Day 2025

· Cosmo Pharmaceuticals NV

Cosmo N.V., a global leader in AI-driven healthcare and specialty pharmaceuticals, today announced its vision through 2030, along with a bold strategic plan, during its Investor Day event in Zurich.

Download press release (PDF)

← All news